Five Prime Therapeutics Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Five Prime Therapeutics Inc with three other
companies in this sector in the United States:
Albany Molecular Research Incorporated
sales of $402.36 million
of which 54%
Insys Therapeutics Incorporated
of which 100%
was Non-Drug Products).
Sales increased substantially in 2015:
Five Prime Therapeutics Inc reported sales of $379.80 million
December of 2015.
increase of 1,874.9%
versus 2014, when the company's sales were $19.23 million.
This was the third consecutive year of growth at Five Prime Therapeutics Inc.